Navigate Complex Regulatory Pathways with Confidence
Indivirtus Healthcare Services provides expert regulatory support for pharmaceutical and biopharmaceutical organizations targeting approvals from FDA, EMA, PMDA, and WHO. Our comprehensive services streamline dossier preparation, submission, and lifecycle management, ensuring compliance and timely market access.
Global submission support involves preparing, reviewing, and submitting regulatory dossiers to agencies like FDA, EMA, PMDA, and WHO. It ensures compliance with region-specific requirements, facilitating approvals for pharmaceuticals and biopharmaceuticals.
Navigating complex regulatory landscapes is essential for market access. Expert support minimizes errors, accelerates approvals, and ensures compliance with global standards, reducing delays and costly revisions.
Indivirtus Healthcare Services acts as your trusted partner, offering end-to-end regulatory support. From initial submissions to post-approval lifecycle management, our team aligns strategies with agency requirements to ensure seamless approvals.
At Indivirtus Healthcare Services, we deliver tailored regulatory support backed by a team of certified professionals with extensive global experience. We guide you through every step of the submission process, from dossier compilation to query responses and lifecycle management. Our services include strategic alignment with country-specific regulations, ensuring compliance with FDA, EMA, PMDA, and WHO standards. We also manage Drug Master Files (DMF) and Certificates of Suitability (CEP), providing robust support for initial submissions, variations, and post-approval changes. Our proactive approach minimizes risks and accelerates your path to market.
Agency-Specific Submission Dossier: Tailored dossiers meeting the requirements of FDA, EMA, PMDA, or WHO for seamless approvals.
Query Response Documentation: Comprehensive responses to regulatory queries, ensuring clarity and compliance.
CEP/DMF Lifecycle Reports: Detailed reports for managing Drug Master Files and Certificates of Suitability throughout their lifecycle.
Submission Timelines & Status Dashboards: Real-time tracking tools to monitor progress and ensure timely submissions.
Our global submission support services adhere to the highest regulatory standards, ensuring your dossiers are robust, compliant, and audit-ready. By aligning with agency-specific guidelines and international frameworks, we help you achieve global market access while maintaining compliance with regional requirements. Our expertise in electronic Common Technical Document (eCTD) submissions ensures efficiency and accuracy across all regulatory submissions.
Our global submission support services are designed for pharmaceutical and biopharmaceutical companies at various stages of their regulatory journey. Whether you’re seeking initial market approval, managing post-approval variations, or navigating complex multi-region submissions, we provide tailored solutions. Our services are ideal for new drug applications, generic drug submissions, biologics, and biosimilars. We also support lifecycle management for DMFs and CEPs, ensuring continued compliance and market access. From startups to established manufacturers, our expertise helps you achieve regulatory success efficiently.
Indivirtus Healthcare Services stands out with our team of certified regulatory experts and toxicologists, bringing global experience to every project. Our scientifically defensible submissions and rapid turnaround times ensure your regulatory goals are met efficiently. We prioritize confidentiality, adhering to industry best practices to protect your sensitive data. With a proven track record of successful FDA, EMA, PMDA, and WHO submissions, we are your trusted partner for achieving global market access and maintaining compliance throughout your product’s lifecycle.
We support submissions to FDA, EMA, PMDA, WHO, and various country-specific regulatory authorities.
Yes, we provide strategic support in drafting and submitting responses to agency queries post-filing.
Absolutely. We manage the entire lifecycle including variations, renewals, and compliance updates.
Yes, we offer full support for WHO Prequalification submissions, including dossier preparation and audit readiness.
We typically require the product dossier, manufacturing process details, prior correspondence, and supporting documents as per regional requirements.
Global submission support involves preparing and submitting regulatory dossiers to agencies like FDA, EMA, PMDA, and WHO to secure drug approvals. It’s critical for ensuring compliance, minimizing delays, and achieving market access in multiple regions.
We provide expert support for submissions to the FDA, EMA, PMDA, and WHO, ensuring compliance with each agency’s specific requirements.
We support initial drug applications, generic drug submissions, biologics, biosimilars, DMF/CEP lifecycle management, and post-approval variations, tailored to your needs.
Our deliverables include agency-specific dossiers, query response documentation, CEP/DMF lifecycle reports, and submission timelines with status dashboards for real-time tracking.
We adhere to strict confidentiality protocols and industry best practices, safeguarding your sensitive data throughout the regulatory submission process.
The electronic Common Technical Document (eCTD) format ensures efficient, standardized, and accurate submissions, reducing errors and speeding up the review process with regulatory agencies.